iTeos Therapeutics, Inc. insider trading activity

Understanding Insider Activity at iTeos Therapeutics, Inc.

Welcome to our dedicated page for iTeos Therapeutics, Inc. (Nasdaq: ITOS) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by iTeos Therapeutics, Inc.'s key insiders, providing a unique window into the company's internal sentiments.

How to Use This Data:

Below, you can view insider transactions that were reported to the SEC within the last 365 days.

While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.

Scroll down to view the most recent insider transactions for iTeos Therapeutics, Inc., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.

Track insider trades for ITOS
TickerTime & DateFilingLink
ITOS12:59:14 AM, 11/20/2024
Gall Matthew(Chief Financial Officer) purchased 5000 shares of iTeos Therapeutics, Inc. (ITOS) for ~$38650
Filing
ITOS09:09:33 PM, 10/12/2023
Gall Matthew(Chief Financial Officer) purchased 5000 shares of iTeos Therapeutics, Inc. (ITOS) for ~$41849
Filing
ITOS01:28:31 AM, 08/26/2023
Boxer Capital, LLC sold 350000 shares of iTeos Therapeutics, Inc. (ITOS) for ~$5692672
Filing